Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2003-07-18
2008-03-18
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C530S350000
Reexamination Certificate
active
07344718
ABSTRACT:
A method of protecting an animal from infections with pathogens originating fromYersiniacomprising administering an isolated or recombinant YscF protein to the animal is disclosed. The isolated or recombinant YscF protein may be administered as a vaccine. An isolated or recombinant YscF protein capable of conferring protection to an animal against a pathogen of aYersiniaorigin is further disclosed. Nucleic acid molecules encoding the isolated or recombinant YscF protein are also disclosed. In other embodiments, antibodies generated against the isolated or recombinant YscF protein capable of conferring protection to an animal against a pathogen or aYersiniaorigin and uses of the antibodies are described.
REFERENCES:
patent: 5985285 (1999-11-01), Titball et al.
patent: 6261561 (2001-07-01), Stewart et al.
patent: WO 95/18231 (1995-07-01), None
patent: WO 96/28551 (1996-09-01), None
patent: WO 98/24912 (1998-06-01), None
patent: WO 02/077249 (2002-10-01), None
Plotkin et al (VACCINES W B Saunders Co. 1988, p. 571).
8th International Symposium on Yersinia, Sep. 4-8, 2002. Turku, Finland.
Benner et al., Immune Response to Yersinia Outer Proteins and Other Yersinia pestis Antigens after Experimental Plague Infection in Mice, Infection and Immunity, Apr. 1999, pp. 1922-1928, vol. 67, No. 4.
Edqvist et al., YscP and YscU Regulate Substrate Specificity of the Yersinia Type III Secretion System, Journal of Bacteriology, Apr. 2003, pp. 2259-2266, vol. 185, No. 7.
Hoiczyk et al., Polymerization of a single protein of the pathogen Yersinia entercolitica into needles punctures eukaryotic cells, PNAS, Apr. 10, 2001, pp. 4669-4674, vol. 98, No. 8.
Titball et al., Vaccination against bubonic and pneumonic plague, Vaccine, 2001, pp. 4175-4184, vol. 19.
Williamson, E.D., Plague vaccine research and development, Journal of Applied Microbiology, 2001, pp. 606-608, vol. 91.
Wilson et al., Role of EscF, a putative needle complex protein, in the type III protein translocation system of enteropathogenicEscherichia coli, Cellular Microbiology, 2001, pp. 753-762, vol. 3, No. 11.
Michiels et al., Analysis of virC, an Operon Involved in the Secretion of Yop Proteins by Yersinia enterocolitica, Journal of Bacteriology, Aug. 1991, pp. 4994-5009, vol. 173, No. 16.
Hu et al., Structural Organization of Virulence-Associated Plasmids of Yersinia pestis, Journal of Bacteriology, Oct. 1998, pp. 5192-5202, vol. 180, No. 19.
Supplementary Partial European Search Report, EP 04 74 9309, dated Mar. 29, 2007.
Matson Jyl S.
Nilles Matthew L.
Navarro Mark
TraskBritt
University of North Dakota
LandOfFree
Yersinia species compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Yersinia species compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Yersinia species compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3978744